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Background: There is limited data on the risk factors and characteristics of the recurrence of behavioral
and psychological symptoms of dementia (BPSD) in patients with Alzheimer’s disease (AD).
Methods: One hundred and two AD patients complaining of BPSD were followed-up for 12 months after
being well controlled. Potential risk factors for the recurrence of BPSD were evaluated. The severity of
BPSD was measured using the Neuropsychiatric Inventory (NPI). NPI syndromes were categorized into
affective impairments, psychotic symptoms, and lack of control disorders. Characteristics of the recurrent
BPSD were compared with those of the former onset.
Results: Forty-ﬁve of the patients presented recurrent BPSD within 12 months. Risk factors of recurrence
included change of environment (RR ¼ 5.42, p < 0.001), failure to maintain antipsychotic medication
(RR ¼ 3.13, p < 0.001), and high NPI score (RR ¼ 1.06, p ¼ 0.023) at the former onset. Both the number
of symptoms and the affective subscores were correlated (r ¼ 0.93, p ¼ 0.011; r ¼ 0.79, p ¼ 0.016,
respectively) and showed no signiﬁcant difference between the two adjacent onsets of BPSD. The NPI
total score (18.29  2.06 vs. 20.80  3.78, p ¼ 0.031) and the psychotic subscore (6.49  1.80 vs.
7.73  1.92, p ¼ 0.033) were signiﬁcantly lower in the recurrent onset than those in the former and the
two values showed no signiﬁcant correlation between the two onsets. Subscores of lack of control of the
two onsets were neither correlated nor different statistically from each other.
Conclusion: Change of environment, failure to maintain antipsychotic medication, and high NPI score at
the former onset are risk factors for the recurrence of BPSD. Proﬁles of two onsets in the same patient are
not always the same. The severity of BPSD and its psychotic symptoms show a tendency to ameliorate
with the progression of AD. Affective impairments appear to be consistent. Lack of control disorders may
be variable.
Copyright  2013, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC.  Open access under CC BY-NC-ND license.1. Introduction
Behavioral and psychological symptoms of dementia (BPSD) are
common clinical syndromes in patients with Alzheimer’s disease
(AD). The incidence of BPSD was reported to be 50e80% in AD
patients,1,2 which can occur in any period of the disease. Non-
pharmacological treatment is recommended as the ﬁrst choice in
most of the dementia treatment guidelines. However, we some-
times have to treat BPSD with antipsychotic medicine orPsychiatry, Beijing Geriatric
ict, Beijing 100095, People’s
linical Gerontology & Geriatrics. Pantidepressants to control some dangerous activities. Regardless,
the recurrence of BPSD is common. It was reported abroad that the
recurrence rate (RR) of BPSD was 85e90% within 12 months of
follow-up.3 Sheng et al4 reported that the recurrence rate of BPSD
was 27e57% within 6 months, even when the patients received
maintenance therapy with antipsychotic medications, and the
recurrent BPSD is not just a repetition of the former onset. How-
ever, there are still uncertainties about recurrent BPSD. Firstly, the
risk factors of BPSD remain unknown. Secondly, opinions on
whether or not the patients should continue using antipsychotic
medicine after one BPSD onset are conﬂicting.5,6 Thirdly, data
concerning the similarities and differences between the adjacent
onsets of BPSD are limited. Consequently, the prevention and
management of BPSD is difﬁcult. In this study, we therefore focusedublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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characteristics of recurrent BPSD. Our aim is to discover evidence
beneﬁcial to the prevention and management of the recurrence of
BPSD.
2. Methods
2.1. Participants
2.1.1. Inclusion criteria
Patients with AD diagnosed according to the criteria for prob-
able AD as deﬁned by the National Institute of Neurological Dis-
orders and Stroke-Alzheimer’s Disease and Related Disorders
Association (NINCDS-ADRDA); aged  60 years; complaining of
BPSD and being well controlled within 1 month of admission;
admitted to Beijing Geriatric Hospital from July 2007 to July 2009,
and completed 12 months of follow-up. As in previous reports, in
this study BPSD was considered well controlled if the Neuropsy-
chiatric Inventory (NPI) total score was <4 and it was considered
BPSD onset or recurrence (at least 1month interval from the former
onset) if NPI total score was 4.1,7 Consent was obtained from all
patients or their family members.
2.2. Data collection
Demographic characteristics were collected at baseline,
including age, sex, education level, marriage status, etc. Potential
inﬂuential factors of recurrence of BPSD were also collected,
including onset age, course, cognitive level, ability for daily life
activities, severity of BPSD, etc. Severity of BPSD was reassessed
1 month after admission. Patients whose BPSD was controlled were
followed-up continually. Those whose BPSD was not well
controlled were excluded from the study. The following informa-
tion concerning the participants was collected until the recurrence
of BPSD or up to the 12-month follow-up limitation: whether or not
maintaining the use of antipsychotic medicine (continuing to take
the antipsychotic medicine after the BPSD was well controlled for
no less than 12 weeks). Anti-dementia, antidepressant, sedative,
and anxiolytic medications were not considered in this study, with
or without environment change (change of residence or caregiver),
and regardless of the severity of the recurrent BPSD.
2.2.1. Assessment tools
(1) Severity of BPSD was assessed with Neuropsychiatric In-
ventory (NPI),8 the score of which ranges from 0 to 120. The 10
items of NPI were categorized into three syndromes: affective im-
pairments (apathy/indifference, depression/dysphoria, and anxi-
ety), psychotic symptoms (hallucination and delusion), and lack of
control disorders (disinhibition, elation/euphoria, agitation/
aggression, irritability/lability, and motor disturbance).9,10 (2)
Cognitive function was assessed with the Mini-Mental State
Examination (MMSE). (3) Ability to perform daily living activities
was assessed with Activity of Daily Living (ADL). All data were
collected by investigators specially trained for this study, including
doctors, nurses, and medical students.
2.3. Statistical analysis
Assessed with the One-Sample Kolmogorov-Smirnov test, all
continuous variables displayed approximately normal distribution,
except time of BPSD recurrence; these were then expressed as
mean  standard deviation (SD). Continuous variables from
groups or two BPSD onsets were analyzed using an independent t
test or paired t test. The Pearson Chi-square test was used to
analyze all the categorical data from groups or two BPSD onsets.The correlation between values of two adjacent onsets was
assessed using the intraclass correlation coefﬁcient. The Cox
regression model was used to analyze the potential risk factors for
BPSD recurrence. Data was analyzed using SPSS, version 15 (SPSS
Inc., Chicago, IL, USA). A value of p < 0.05 was considered statis-
tically signiﬁcant.2.4. Ethics approval
The study was approved by the Ethics Committee of Beijing
Geriatric Hospital. All participants or their legal representatives
gave their written consent.3. Results
3.1. Demographics
A total of 102 patients met the inclusion criteria. Of these, 54
were men and 48 were women. Their ages ranged from 60 years to
89 years (mean  SD, 70.29  9.01 years). Their disease courses
ranged from 2 years to 7 years (mean SD, 3.14 2.22 years). Their
onset ages ranged from 55 years to 84 years (mean  SD,
67.21  10.19 years).3.2. Characteristics of BPSD recurrence
Ninety (88.2%) patients presented two or more symptoms of NPI
during the study period (at baseline or follow-up). Forty-ﬁve
(44.1%) patients presented recurrent BPSD and 57 (55.9%) did not.
The recurrent time ranged from 5 weeks to 51 weeks, with a me-
dian of 14 weeks. The most frequently recurring symptoms were
depression/dysphoria (41.0%, 32/78), apathy/indifference (40.5%,
32/79), and disinhibition (36.0%, 18/50).3.3. One-way analysis of BPSD recurrence
The potential risk factors were compared between the recur-
rent group and the nonrecurrent group, including age, sex, onset
age of dementia, course of dementia, baseline MMSE score,
baseline NPI score, baseline ADL score, with or without environ-
ment change, and whether or not maintaining the use of anti-
psychotic medicine. The baseline NPI score and MMSE score of the
BPSD recurrent group were higher than those of the BPSD
nonrecurrent group (p ¼ 0.024; p ¼ 0.019). There are more pa-
tients with environment change and more patients without
maintenance of antipsychotic medication in AD patients with
recurrent BPSD than in those without recurrent BPSD (both
p < 0.001), as shown in Table 1.3.4. Cox regression analysis of recurrence of BPSD
Cox regression analysis was carried out with recurrence of BPSD
as the dependent variable, and with the signiﬁcant inﬂuential
factors in the above One-way Analysis of BPSD recurrence as in-
dependent factors, including the baseline NPI score, the MMSE
score, with/without environment change, and with/without
maintenance of antipsychotic medications. Baseline NPI score
(RR ¼ 1.06, 95% CI: 1.02e1.11, p ¼ 0.023), environment change
(RR ¼ 5.42, 95% CI: 2.26e13.04, p < 0.001), and no maintenance of
medicine (RR ¼ 3.13, 95% CI: 1.21e8.06, p < 0.001) were ﬁnally
included in the model. Baseline MMSE score was excluded from the
model (RR ¼ 1.04, 95% CI: 0.97e1.11, p ¼ 0.058).
Table 1
Comparison of potential inﬂuential factors between behavioral and psychological symptoms of dementia (BPSD) recurrent patients and nonrecurrent patients.
Groups n NPI score at acute onset ADL score MMSE score Course of AD Onset age Age
Recurrent cases 45 20.80  3.78a 41.32  10.41 16.64  4.33a 2.71  1.83 67.98  8.84 70.61  8.42
Nonrecurrent cases 57 15.85  6.46 43.96  15.10 13.34  6.51 3.48  2.54 66.61  11.30 70.04  9.71
Groups n Female Environment
change
Being
widowed
No maintenance of
antipsychotic
medication
Education level
Primary Middle High
Recurrent cases 45 19 (42.2) 35 (77.8)b 19 (42.2) 35 (77.8)b 13 (28.9) 19 (42.2) 13 (28.9)
Nonrecurrent
cases
57 29 (50.9) 9 (15.8) 22 (38.6) 10 (17.5) 11 (19.3%) 35 (61.4) 11 (19.3)
Data are presented as mean  SD or n (%).
AD ¼ Alzheimer’s disease; ADL ¼ Activity of Daily Living; MMSE ¼ Mini-Mental State Examination; NPI ¼ Neuropsychiatric Inventory.
a Compared with nonrecurrent cases, by t test, p < 0.05.
b Compared with nonrecurrent cases, by Chi-square test, p < 0.001.
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adjacent BPSD
Mean symptom numbers of baseline and recurrent BPSD were
both four to ﬁve and there was no signiﬁcant statistical signiﬁcance
analyzed with the paired t test (p ¼ 0.407). Mean symptom
numbers of the two adjacent BPSD onsets were closely correlated
(r ¼ 0.93, p < 0.011). There was no signiﬁcant correlation between
either NPI scores or psychotic symptom subscores of the two
adjacent onsets (p ¼ 0.122 and p ¼ 0.394, respectively). Both NPI
scores and psychotic symptom subscores at the recurrent onset
were signiﬁcantly lower than at the former onset (p ¼ 0.031 and
p ¼ 0.033, respectively). Affective impairment subscores of the two
BPSD onsets were signiﬁcantly correlated (r ¼ 0.79, p ¼ 0.016) and
were not signiﬁcantly different from each other (p ¼ 0.462). There
was no signiﬁcant correlation between the lack of control subscores
of the two BPSD onsets (r ¼ 0.11, p ¼ 0.320). There was no signiﬁ-
cant difference between the lack of control subscores of the two
BPSD onsets (5.80  2.30 vs. 5.78  1.65, p ¼ 0.063), as shown in
Table 2.
4. Discussion
In this study, 102 AD patients complaining of BPSD were
followed-up for 12 months after being well controlled. Recurrence
rate and risk factors for recurrence were evaluated and character-
istics of symptoms of the two adjacent onsets were compared.
Forty-ﬁve (44.1%) of the 102 AD patients presented recurrent BPSD,
consistent with other reports from China4 but much lower than one
follow-up study in an overseas clinic in which the recurrent rate is
85e90%.3 The diversity might have been caused by the difference of
origin and method. Of the patients with BPSD, 88.2% exhibited
multiple symptoms in this study and the mean numbers of symp-
toms of both BPSD onsets were four to ﬁve. These indicated that the
presentation of BPSD in AD patients was complex and symptoms
were often multiple. In previous reports, 39.7%2 or 55%1 of patientsTable 2
Correlation and comparison between the characteristics of the baseline onset and the re
Groups Symptom
number
NPI total score
Baseline onset 4.51  0.87 20.80  3.78
Recurrence 4.22  1.11 18.29  2.06a
ICC coefﬁcient, r 0.93b 0.35
Data are presented as mean  SD unless otherwise indicated.
ICC ¼ intraclass correlation coefﬁcient; NPI ¼ Neuropsychiatric Inventory.
a Compared with baseline onset, by paired-samples t test, p < 0.05.
b p < 0.05.with BPSD presented two or more symptoms. The reasonwhymore
patients presented multiple symptoms in this study might be that
the patients we included were all AD patients complaining of BPSD.
Their psychotic and behavioral disorders must be more serious
than those from communities or common inpatients.
Results from the Cox regression showed that baseline NPI score,
change of environment, and failure to maintain psychotic medicine
were risk factors for BPSD. In these factors, change of environment
was an important risk factor for recurrent BPSD, with an RR of 5.42.
This is consistent with most of the previous studies, where it was
found that familiar environment and consistent caregivers are
beneﬁcial to dementia patients.11 However, long term care for de-
mentia patients causes more serious caregiver burden. How to
balance the beneﬁt to dementia patients and their caregivers is a
question that needs to be resolved. The ratio of BPSD recurrence
increases 1.06 times, with the NPI score increasing one point at
baseline onset (RR ¼ 1.06). This indicates that severe BPSD onset is
one of the risk factors of its recurrence. The recurrence risk of pa-
tients who discontinue use of antipsychotic medicine is 3.13 times
greater than the risk of those with maintenance of antipsychotic
medicine (RR ¼ 3.13). This indicates that maintenance of antipsy-
chotic medicine use for at least 12 weeks after acute BPSD onset
could reduce recurrence risk within 12 months. The long term ef-
fect of the maintenance of antipsychotic medicine must still be
evaluated in further follow-up.
Opinion on the maintenance of antipsychotic medicine is
controversial. Some researchers believe that BPSD recurrence is not
inﬂuenced by maintenance of antipsychotic medicine use and
many BPSD symptoms could improve independently in 1 year.12
However, severe psychotic and behavioral disorders undoubtedly
interfere with the living functions and life quality of patients.
Caregiver burden is also increased. Therefore, more researchers
assert that application of antipsychotic medicine is still an impor-
tant therapy for BPSD.
Although there was a signiﬁcant difference in the MMSE score
between the BPSD recurrent group and BPSD nonrecurrent group,current behavioral and psychological symptoms of dementia (BPSD).
Score of affective
items
Score of psychotic
items
Score of lack of
control items
7.29  2.06 7.73  1.92 5.78  1.65
7.00  1.87 6.49  1.80a 5.80  2.30
0.79b 0.28 0.11
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model. Thus, it could not be concluded that cognitive level has a
signiﬁcant effect on BPSD recurrence. This is consistent with pre-
vious studies where cognitive decline and BPSD in dementia pa-
tients are independent and heterogeneous dimensions. Their
pathological mechanisms may have become different as different
neurotransmitter systems were affected.13,14 Thus, the cognitive
decline and BPSD syndromes of AD patients should be considered
independently and treated individually.
From the result of characteristics of BPSD recurrence, we can see
that there was no signiﬁcant difference between the two adjacent
BPSD onsets in symptom numbers and in affective impairment
subscores. Both symptom numbers and affective impairment sub-
scores were correlated between the two adjacent BPSD onsets.
These indicate that the multiple symptoms of BPSD tend to present
continuously. Among them, the performance and severity of af-
fective impairments appear to be more consistent. Wilson et al15
reported there were no obvious changes in depression mood dur-
ing the progress of AD. There was neither a signiﬁcant correlation,
nor a signiﬁcant difference between the two BPSD onsets in sub-
scores of lack of control disorders, indicating that there is no
obvious rule in different BPSD onsets in a given patient. Both the
NPI score and the psychotic symptoms subscore at the recurrent
onset were signiﬁcantly lower than at the former onset, indicating
that there was a tendency to ameliorate in the overall severity of
BPSD and psychotic symptoms. The NPI score and the psychotic
symptoms subscore between the two adjacent onsets were not
signiﬁcantly correlated, indicating that the extent of ﬂuctuation
was inconsistent in different patients.
A population-based study in the United States reported that 81%
of those with neuropsychiatric symptoms at baseline continued to
have at least one symptom at follow-up.16 There are three possible
reasons for the inconsistency between their study and this study.
Firstly, their observation points were selected in advance. Thus, the
patients could be at an acute BPSD onset or at a stable stage when
they were evaluated. However, in this study, all patients were
enrolled from a clinic complaining of acute BPSD. Secondly, the US
studywas community-based and therefore patients were less likely
to receive medicine therapy or behavioral management (lack of
information on the treatment in their study). It is not difﬁcult to
understand that more persist BPSD was observed in their study.
Contrary to the US study, this study was clinic-based and the BPSD
of all patients was well controlled at the start of the follow-up. The
rate and performance of recurrent BPSD could both be inﬂuenced
by the drug therapy and were not natural courses.
In the study by Sheng et al,4 with a sample of 10 AD patients and
four patients with vascular dementia, the recurrent symptoms of
BPSD were mainly delusion, motor disturbances, and aggression,
which were signiﬁcantly correlated with the former onset. In their
study, the overall severities of BPSD were not correlated with each
other in the two BPSD onsets. However, all 102 patients in this
study were AD patients. Differences in the results were probably
caused by the difference of the size and diagnosis of samples in
various studies. In addition, the prevalence of BPSD symptoms
increased with the progress of dementia.17 Most of the patients weenrolled suffered moderate to severe AD, which may lead to the
limitations of the study.
In conclusion, it is common for BPSD to recur during the course
of AD. The performance of BPSD is complex. Clinicians should make
efforts to prevent BPSD recurrence. Every onset of BPSD should be
treated individually.Acknowledgments
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